Background: Coronavirus disease 2019 (COVID-19) is associated with high rates of thromboembolic events in hospitalized patients. It remains to be determined if this risk persists following hospital discharge. Methods: We conducted a retrospective cohort study of outpatients recently hospitalized for COVID-19 to determine the incidence of vascular thromboembolic events within 30 days of discharge. We investigated the risk factors associated with these events, including intensive care admission, age, and anticoagulation. Results: Among 447 patients hospitalized for COVID-19, 2.0% experienced a vascular thromboembolic event within 30 days of discharge. No risk factor variable was significantly associated with an increased risk for these events. Conclusions: The incidence of vascular thromboembolic events following hospital discharge for COVID-19 is low. These findings suggest against the routine use of postdischarge thromboprophylaxis in patients with COVID-19.
CITATION STYLE
Eswaran, H., Jarmul, J. A., Shaheen, A. W., Meaux, D., Long, T., Saccoccio, D., & Moll, S. (2021). Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors. Research and Practice in Thrombosis and Haemostasis, 5(2), 292–295. https://doi.org/10.1002/rth2.12485
Mendeley helps you to discover research relevant for your work.